Dermatological toxicity in women with breast cancer undergoing chemotherapy treatment;Toxicidade dermatológica em mulheres com câncer de mama submetidas à quimioterapia

Revista Latino-Americana de Enfermagem

Volumn 18, Issue 4, 2010, Pages 681-687

  de Oliveira Gozzo, Thais ^a   Panobianco, Marislei Sanches ^a   Clapis, Maria José ^a   de Almeida, Ana Maria ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Breast neoplasms; Drug therapy; Extravasation of diagnostic and therapeutic materials; Nursing

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; ARTICLE; BREAST TUMOR; CAUCASIAN; COMPARATIVE STUDY; CONTRAST MEDIUM EXTRAVASATION; DRUG EFFECT; EVALUATION; FEMALE; HUMAN; MIDDLE AGED; NEGRO; NURSING; PHOTOGRAPHY; PUNCTURE; RACE; SKIN;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CONTINENTAL POPULATION GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; FEMALE; HUMANS; MIDDLE AGED; NEOADJUVANT THERAPY; PHOTOGRAPHY; PUNCTURES; SKIN;

EID: 78349295257     PISSN: 01041169     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0104-11692010000400004     Document Type: Article

References (12)

1. a ed. Rio de Janeiro (RJ): Atheneu; 2005.
2. National Cancer Institute. Common toxicity criteria, Version 2.0. [online]1999., [acesso em: 20 junho 2007] Disponível http://safetyprofiler-ctep.nci.nih.gov/CTC/CTC.aspx.
3. Schulmeister L. Extravasation management. Semin Oncol Nurs. 2007;23(3):184-90.
4. Dougherty L. IV therapy: recognizing the differences between infiltration and extravasation. Br J Nurs. 2008;17(4):896-901.
5. a ed. Rio de Janeiro (RJ): Guanabara Koogan; 2002.
6. Wickam R, Engelking C, Sauerland C, Corbi D. Vesicant extravasation part II: Evidence-based management and continuing controversies. Oncol Nurs Forum. 2006;33 (6):1143-50.
7. Schulmeister L. Managing vesicant extravasations. Oncologist 2008;13:284-8.
8. Goolsby TV, Lombardo FA. Extravasation of chemotherapeutic agents: prevention and treatment. Semin Oncol. 2006;33(1):139-43.
9. Ener RA, Meglathery SB, Styler M. Extravasation os systemic hemato-oncological therapies. Ann Oncol. 2004;15:858-62.
10. o 210/1998. Dispõe sobre a atuação dos profissionais de Enfermagem que trabalham com quimioterápico antineoplásicos. Brasília; maio 2006. Disponível em: http://inter.coren-sp.gov.br/node/3951
11. Saurland C, Engelking C, Wickham R, Corbi D. Vesicant Extravasation Part I: Mechanisms, Pathogenesis, and Nursing Care to Reduce Risk. Oncol Nurs Forum. 2006;33(6):1134-41.
12. Boyle DM, Engelkin C. Vesicant extravasation: myths and realities. Oncol Nurs Forum. 1995;22:57-67.